Cg Oncology Inc.

WebsiteDirections EnrollContact us

$16.00
OFF

CG Oncology Inc. | IPOScoop

4 weeks from now

Jan 25, 2024 · Background: CG Oncology, Inc. filed an S-1/A on Jan. 18, 2024, disclosing terms for its IPO: 11.8 million shares at a price range of $16.00 to $18.00 to raise $200.6 million. …

iposcoop.com

$200
OFF

The IPO Buzz: CG Oncology Sets Terms & Launches …

4 weeks from now

Jan 18, 2024 · B ladder cancer biotech CG Oncology (CGON Proposed) unveiled the terms and launched its $200.6 million IPO shortly before sunrise on Wall Street today – Thursday, Jan. …

iposcoop.com

$19
OFF

The IPO Buzz: CG Oncology Prices Upsized IPO At $19 – …

4 weeks from now

T wice: Bladder cancer biotech CG Oncology (CGON) upsized its IPO for the second time this week – by pricing 20.0 million shares at $19.00 – $1.00 above the top of its range – to raise …

iposcoop.com

$380
OFF

CG Oncology Prices Larger-than-expected $380M IPO In …

4 weeks from now

Jan 24, 2024 · Cancer drug developer CG Oncology has raised $380 million in an initial public offering than was larger than it expected, a positive sign for a sector that’s struggled to …

biopharmadive.com

$380
OFF

CG Oncology Is First Biotech IPO Of 2024, Raising $380m

4 weeks from now

Jan 25, 2024 · CG Oncology has taken the ribbon for the first biotech initial public offering (IPO) of the new year and its $380 million raise – which far outstrips the proceeds forecast – backs up …

pharmaphorum.com

96%
OFF

CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal …

4 weeks from now

Jan 25, 2024 · Irving, Calif.-based CG Oncology's stock (CGON) closed its first day of trading at $37.17 a share, up 95.6% from its $19 IPO price and well above its opening trade of $29 a share.

morningstar.com

$209
OFF

CG Oncology Aims For $209M IPO, As More Biotechs Eye …

4 weeks from now

Jan 18, 2024 · CG Oncology is hoping to raise $209 million from its upcoming IPO, blazing a trail to the public markets that seems to be enticing more biotechs in the first month of the year.

fiercebiotech.com

$19.00
OFF

The IPO Buzz: CG Oncology (CGON) Scores A NASDAQ …

4 weeks from now

C G Oncology (CGON) – the first biotech IPO of the year – scored a moonshot today in its NASDAQ debut. The bladder cancer biotech doubled its $19.00 IPO price – rising to $38.00 …

iposcoop.com

6%
OFF

Cancer Drug Developer CG Oncology Valued At $1.75 Bln In …

4 weeks from now

Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …

reuters.com

$1
OFF

CG Oncology Targets Near $1 Bln Valuation In US IPO

4 weeks from now

Jan 18, 2024 · At the top end of the proposed range, CG Oncology would raise around $212 million. Morgan Stanley, Goldman Sachs, Cantor and LifeSci Capital are the underwriters for …

reuters.com

FAQs about Cg Oncology Inc. Coupon?

How much will CG Oncology IPO cost?

The company is offering about 11.8 million shares at a range between $16 and $18 each. At the top end of the proposed range, CG Oncology would raise around $212 million. Morgan Stanley, Goldman Sachs, Cantor and LifeSci Capital are the underwriters for the IPO. The company is seeking to list on Nasdaq under the symbol "CGON". ...

Does CG oncology have a biotech IPO?

CG Oncology's initial public offering (IPO), the first by a biotech firm this year, sets the stage for other healthcare companies such as KKR-backed BrightSpring Health Services and Moderna-backed Metagenomi. Investment in biotech companies over the past two years has been a fraction of historical levels. ...

Will CG oncology raise $100 million in a public offering?

IRVINE, Calif.-- (BUSINESS WIRE)--CG Oncology Announces Pricing of Upsized Initial Public Offering. CG Oncology, a Phase 3 biotech developing an oncolytic immunotherapy for bladder cancer, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. ...

Has CG had an IPO?

CG’s road to an IPO is a sign of the times, as the company has had an IPO. The company raised $308 million before its offering, including a $105 million Series F “crossover” round that bridged it to the public markets. ...

Is CGON's IPO a sign of an early IPO run?

CG Oncology's IPO, which is the biotechnology sector’s first of 2024, could be the start of an early IPO run. The company on Wednesday sold 20 million shares in its offering — eight million more than it had expected — at $19 apiece. Shares will begin trading Thursday on the Nasdaq stock exchange under the ticker symbol “CGON.” ...

Will CG Oncology GO Public?

The firm aims to list on the Nasdaq under the symbol CGON. CG Oncology has filed to go public with an IPO on the NASDAQ. CG Oncology has received fast track designation and breakthrough designation needed to accelerate US FDA submission. ...